Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | glutaminase | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Loa Loa (eye worm) | glutaminase | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Brugia malayi | glutaminase DH11.1 | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Mycobacterium ulcerans | glutaminase | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Loa Loa (eye worm) | glutaminase 2 | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Trichomonas vaginalis | glutaminase, putative | Get druggable targets OG5_129245 | All targets in OG5_129245 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0536 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0438 | 0.7062 | 1 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0438 | 0.7062 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0536 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0438 | 0.7062 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0438 | 0.7062 | 1 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0536 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0438 | 0.7062 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0438 | 0.7062 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0438 | 0.7062 | 1 |
Plasmodium falciparum | esterase, putative | 0.0438 | 0.7062 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0438 | 0.7062 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0438 | 0.7062 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0438 | 0.7062 | 1 |
Schistosoma mansoni | amidase | 0.0536 | 1 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0438 | 0.7062 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0438 | 0.7062 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0438 | 0.7062 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0536 | 1 | 1 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0438 | 0.7062 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0536 | 1 | 1 |
Leishmania major | monoglyceride lipase, putative | 0.0438 | 0.7062 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0438 | 0.7062 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0438 | 0.7062 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0438 | 0.7062 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0438 | 0.7062 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0536 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0438 | 0.7062 | 0.5 |
Schistosoma mansoni | glutaminase | 0.033 | 0.3791 | 0.3791 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0438 | 0.7062 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0438 | 0.7062 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.4654 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.5821 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | = 112.2018 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.